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Abstract
Electronic health records (EHRs) are increasingly used for clinical and compara-
tive effectiveness research, but suffer from missing data. Motivated by health services
research on diabetes care, we seek to increase the quality of EHRs by focusing on miss-
ing values of longitudinal glycosylated hemoglobin (A1c), a key risk factor for diabetes
complications and adverse events. Under the framework of multiple imputation (MI),
we propose an individualized Bayesian latent profiling approach to capture A1c mea-
surement trajectories subject to missingness. The proposed method is applied to EHRs
of adult patients with diabetes in a large academic Midwestern health system between
2003 and 2013 and had Medicare A and B coverage. We combine MI inferences to
evaluate the association of A1c levels with the incidence of acute adverse health events
and examine patient heterogeneity across identified patient profiles. We investigate
different missingness mechanisms and perform imputation diagnostics. Our approach
is computationally efficient and fits flexible models that provide useful clinical insights.
Key words: Trajectory, Latent profile, Multiple imputation, Sensitivity analysis
1 Introduction
1.1 Glycemic testing and control
Diabetes is a condition requiring intensive management, and a major cause of morbidity and
mortality. Approximately 25.2% of American seniors have diabetes and would benefit from
individualized guidelines on glycemic testing and control (The Centers for Disease Control
and Prevention 2017), but little clinical evidence exists to develop such plans. Current
evidence-based guidelines encouraging tight glycemic control are most applicable to relatively
healthy patients with diabetes. Glycemic control is usually monitored through glycosylated
hemoglobin (A1c), which reflects blood glucose values over approximately the last 3 months.
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The American Diabetes Association (ADA) recommends A1c testing at least two times a year
in patients who are meeting treatment goals and have stable glycemic control, and quarterly
in patients whose therapy has changed or who are not meeting glycemic goals (ADA 2018a).
Individuals without diabetes have A1c values below 5.7%, and maintaining A1c below 7%
is recommended for individuals with diabetes to avoid chronic diabetes complications (ADA
2018a).
For patients aged 65 years or over and those with comorbid conditions, adhering tightly
to guidelines established for those younger and healthier, might be difficult and diminish
the quality of life. Tight control can lead to acute adverse outcomes, such as hypoglycemic
coma, seizures, falls, fractures, motor vehicle accidents, cardiovascular events, stroke, and
acute renal failure (Allen et al. 2001; Boyd et al. 2005; Davis and Alonso 2004; Kennedy et al.
2002; Pogach et al. 2007; Qaseern et al. 2007; Schech et al. 2007; Shorr et al. 1997). For
example, the ACCORD and ADVANCE trials find that lowering A1c values increases the risk
of cardiovascular death (Dluhy and McMahon 2008; Martin et al. 2006). The relationship
between A1c and adverse outcomes in such patients may be U-shaped, and less stringent
A1c goals may be appropriate (ADA 2018b).
To supplement findings from clinical trials, electronic health records (EHRs) are increas-
ingly a data source for clinical and comparative effectiveness research on improving health
care (Agency for Healthcare Research and Quality 2013; Cebul et al. 2011). The EHR pro-
vides a longitudinal record of patient medical information that is maintained by encounters
in any care delivery setting, and includes key clinical data relevant to patient care, such as
laboratory data (e.g., A1c values), demographics, progress notes, problems, medications, vi-
tal signs, past medical history, immunizations and radiology reports. Linked insurance data,
for example from Medicare (U.S. Center for Medicare & Medicaid Services 2012), provide
information on adverse clinical events through billed claims. However, the quality of EHRs is
reduced by a large amount of intermittent missing data, because data are typically collected
in an unscheduled fashion when the patient seeks care or the physician orders care.
In this article, we aim to use EHR to further understand the relationship between A1c
levels and acute adverse outcomes. Information on adverse outcomes is rarely missing, as it
is obtained from billing records. However, A1c within 3 months prior to an event may not
be available due to the above recommendations. Multiple additional factors could influence
the number of missing A1c values for individual patients. Physician non-adherence to guide-
lines for lab testing will cause missing values. The patient’s health potentially affects the
propensity to test, leading to informative missingness patterns that may cause systematic
estimation bias. As argued by Haneuse and Daniels (2016), the complex interplay between
health care providers and patients could result in various missing data mechanisms. Incorpo-
ration of all available information including patient health status is critical to appropriately
handle missing A1c values from EHRs. Furthermore, capturing A1c trajectories and their
relationship to patient characteristics is of clinical interest for health risk prediction and
guideline establishment.
We propose a Bayesian profiling approach to incorporate patient characteristics and infer
latent groups of A1c measurement trajectories. The measurement trajectories reflect both
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the A1c collection patterns and A1c values across time. The Bayesian profiling approach
is combined with multiple imputation (MI, Rubin (1987)) to produce complete datasets for
general analysis purposes. As an illustration of the MI inference, we evaluate the association
between A1c levels and the incidence of any acute health events, such as hospitalization,
emergency room (ER) visits or death. The main novelty lies in generalizing MI with a
flexible imputation engine, a covariate-dependent latent profile model, to depict nonlinear
longitudinal trajectories and incorporate numerous covariates into the latent profiling.
1.2 Statistical literature on intermittently missing data
Missing A1c values in EHRs present statistical methodology challenges. Intermittent miss-
ing data in large-scale, unbalanced longitudinal studies, where subjects reappear after one
or more missed visits, call for new imputation approaches especially when the missing val-
ues are potentially nonignorable (Little and Rubin 2002) and the observed cases are sparse.
Simple methods (e.g., complete case analysis or last observation carried forward) will distort
the relationship and are not recommended by the National Research Council (2010). Stan-
dard missing data methods in longitudinal studies focus on a common set of pre-specified
and monotone missing times, where a measurement being missing implies that all follow-
up measurements are also missing or dropped from the analysis (e.g., reviews in Ibrahim
and Molenberghs (2009)). Likelihood-based, weighting or factorization approaches for miss-
ing data mainly apply to monotone missingness (Daniels and Hogan 2008). Utilization of
the information collected after subjects reappear will potentially correct bias and increase
estimation efficiency, and the challenge lies in how to appropriately model sparse data struc-
tures with non-monotone missing patterns. Weighting adjustment for longitudinal data with
intermittent missingness is complex and computationally demanding, and there is no con-
sistent recommendation on how the weights should be included in the longitudinal data
modeling (Little and Rubin 2002). Sun and Tchetgen (2016) consider inverse probability
weighting for non-monotone missing at random (MAR) data, whereas we argue that MI pro-
vides a superior solution to coherently utilize all available information and offer flexibility
for model building with broad analytic goals.
We seek a flexible MI engine to predict intermittent missing values. MI separates imputa-
tion and analysis into two steps and propagates the uncertainty due to missing data. Various
MI software packages have been developed assuming data are MAR and based on either joint
multivariate normal distributions, e.g., PROC MI (SAS Institute Inc. 2017), Amelia (King
et al. 2001) and norm (Schafer 1997), or a sequence of fully conditional distributions, e.g.,
IVEware (Raghunathan et al. 2001), mice (Van Buuren and Oudshoorn 1999), and mi (Gel-
man et al. 2015). Multilevel models are embedded with MI to handle correlated data, such as
the packages REALCOM-IMPUTE (Carpenter and Kenward 2013) and pan (Schafer 2016).
However, existing MI software cannot handle high-dimensional data that are subject to high
proportions of intermittent missingness in large-scale longitudinal studies, nor nonignorable
missing values (Si and Reiter 2013).
MI for missing not at random (MNAR) data requires a joint model for the incomplete
variables (i.e., the A1c values) and the missingness indicators (i.e., whether A1c values
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are present on any given occasion). Examples of joint models include selection models,
pattern-mixture models, and shared parameter models (Little 1995; Wu and Carroll 1988).
Assumptions have to be introduced for parameter identification, which cannot be verified
with the available observations, and the computation is non-trivial (Ibrahim et al. 2005).
The longitudinal A1c collection history in EHRs results in sparse observations across a
large number of different missingness patterns and calls for flexible modeling strategies that
account for the time dependency, borrow information across patterns and capture patient
heterogeneity.
We jointly model the A1c missingness patterns and the lab values taking into account pa-
tient characteristics. To achieve parameter identification, dimension reduction and straight-
forward interpretation, we introduce latent profiles and develop a Bayesian profiling multiple
imputation (BPMI) approach. The novel latent profiling can handle ignorable and nonignor-
able missingness under the conditional independence assumption given the latent profiles,
which yields a consistent estimation of parameters that are not associated with the latent
profiles (McCulloch et al. 2016).
We assume that latent profiles are primarily determined by the trajectories of the lon-
gitudinal A1c measurements, including A1c values and potentially the measurement pat-
terns. The latent profiling includes patient characteristics—such as socio-demographics,
healthcare utilization measures, medications, medical complexity indicators, comorbidity
and complications—as covariates that affect the profile assignment. This is an improve-
ment over previous work that required joint modeling of the outcome variables, missingness
indicators and covariates, leading to the need for Monte Carlo integration or approximate
inferences (e.g., Zeldow et al. (2018)). The proposal shares a similar decomposition with Lin
et al. (2004) but differs by the MI framework under the Bayesian paradigm. Besides avoiding
the extra computation step of Monte Carlo integration, the posterior updating of BPMI has
efficiency gains via Gibbs sampling and generates completed datasets for general analysis
purposes.
As important contributions, the paper uses all available information with intermittent
missingness to infer latent groups that are relevant to substantive interpretations, fits flexible
mixture models that can capture irregular data distributions and develops Gibbs samplers to
achieve computational efficiency. We examine the identified profiles and present the profile-
specific characteristics to describe the subgroup heterogeneity.
The paper is organized as follows. Section 2 describes the EHR structure and content.
The BPMI method is presented in detail in Section 3. We compare the new method with
alternative imputation methods via simulation studies in Section 4 and apply it to the EHRs
in Section 5, where our statistical and substantive findings are presented. Section 6 presents
contributions and discusses future extensions.
2 EHR description
We extract the EHR data of adult patients with diabetes who belonged to a large academic
Midwestern health system between 2003 and 2013. Patients are included if they have diabetes
4
defined by a qualifying International Classification of Diseases-9 code for diabetes. We treat
the first four quarters after the initial enrollment in the health care system as the baseline
period (time 0). For inclusion, patients must have baseline A1c values and at least one
available follow-up A1c measurement. Patients are excluded from the analysis if they do
not have continuous Medicare Part A & B fee-for-service, or if they are not seen at a clinic
located in the system with access to laboratory data.
Because A1c reflects mean blood glucose over the preceding three months and quarterly
testing is recommended for many patients, we construct a longitudinal dataset with one
measurement per patient per three-month period (patient-quarter). When there are multiple
A1c values available during the three months, we use the average of the measurements before
the date of first acute health event (e.g., hospitalization, ER visit or death) date if there are
any such events.
Missingness occurs when no measurements are available, or as occurs in a handful of cases
(0.3%) after the first acute event in the quarter. We use the average of collected A1c values
during the first four quarters as the baseline A1c value. Patient eligibility for inclusion is
evaluated each quarter and patients are followed until loss to follow-up (e.g., no longer in
the health system) or death, where for patients who die during the study period, we keep
the patient in the dataset until after the quarter of death. Patients’ various enrollment dates
and lengths of follow-up result in an unbalanced data structure. We identified 7372 patients
with 113761 quarters after baseline and only 57285 available observations. The proportions
of intermittent missingness across patients are as high as 0.97, with a median of 0.50. The
baseline A1c values of 7372 patients center around mean 6.93% and range from 3.55% to
17.1%, showing heterogeneity in glycemic control.
A “spaghetti” plot of A1c values is presented for 30 randomly selected patients in 2.1.
Time trends and trajectories vary between patients, and repeated measurements of the same
patients tend to be correlated. We consider mixed-effects models accounting for within-
patient correlation with random intercepts and slopes with respect to time or functions of
time. While the A1c measurement trajectories present patient heterogeneity, subgroups of
patients could share similar profiles across time. We assume each subgroup to have different
location and scale parameters for the time trends, which results in a mixture distribution
overall.
Our goal is to estimate the A1c trajectories over time and identify latent A1c pattern
groups, where the patient-level covariates affect the group allocation probabilities. The latent
profiling allocation in the model takes into account variables that predict the A1c values or
missingness patterns. EHRs collect a rich set of patient characteristics that could predict
the A1c trajectories and likelihood of missingness patterns. The patient-quarter structure
creates both time-invariant and time-varying variables.
Baseline characteristics include socio-demographics, healthcare utilization measures, med-
ications, complexity, comorbid conditions (Elixhauser et al. 1998), and diabetes complica-
tions, all of which are carried forward (e.g., chronic conditions will be assumed as present
from diagnosis onward). The comorbid patterns are characterized by Hierarchical Condition
Categories (HCC) risk scores. The number of adverse events, such as hospitalization and
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Figure 2.1: Observed A1c values of 30 randomly selected patients. Each line represents one
patient, with segments connecting two available subsequent A1c measurements.
ER visits, and the number of ER visits that did not lead to hospitalization during the first
four quarters, serve as proxy measures of healthcare utilization. A large number of variables
and low prevalence of incidence cause problems in the covariate-dependent allocation, a well-
known problem for latent class analysis (Vermunt 2010). We thus create a summary variable
for each patient capturing the count of conditions with prevalence < 2%. The covariates
themselves could have high co-linear dependence and structural constraints. We use the ob-
served A1c values ignoring the patient-quarter structure and fit an ordinary linear regression
to select the variables that are highly correlated with A1c. We then fit a logistic regression
model to predict the missingness at each quarter and select the variables that are predictive
of the missingness pattern.
The union of the two sets of selected variables results in the covariate list in Table 2.1.
The baseline characteristics are fully observed without missing values. The table shows
that the cohort has a modest number of complex patients. For example, 14% of patients
have Chronic Kidney Disease, 33% suffer from moderate or severe kidney damage, 19% have
Congestive Heart Failure, 21% have Ischemic Heart Disease, and 85% have hypertension.
Time-varying variables include age and the count of physician visits that occurred within
each quarter. On average patients have 2.39 physician visits every three months. We ex-
clude time-varying Body Mass Index (BMI), blood pressure (BP), and elevated low-density
lipoprotein (LDL), previously shown as associated with tight A1c control (Jackson et al.
2006; McFarlane et al. 2002; Niefeld et al. 2003) but subject to high missingness. LDL is
often recommended for annual measurements. Measures such as BP and BMI are usually
available when the patient sees a provider in a face-to-face visit, which occurs at A1c tests.
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Table 2.1: Summary of baseline characteristics: mean (standard deviation) and percentage.
Sociodemographics
Age 69.91 (10.76)
Female 53%
White 93%
Medicaid 14%
Utilization
Adverse event count 0.58 (0.88)
Hierarchical condition categories 1.41 (0.98)
Number of emergency room visits 0.12 (0.37)
Comorbidity and complication
Count of low prevalence conditions 0.21 (0.54)
Chronic kidney disease 14%
Chronic pulmonary disease 18%
Dementia 5%
Depression 16%
Entitlement disability 18%
Eye disease 14%
Hypertension 85%
Hypothyroidism 14%
Fluid and electrolyte disorders 14%
Other neurological disorders 7%
Obesity 16%
Psychoses 9%
Renal failure 7%
Solid tumor without metastasis 6%
Lower extremity ulcer 7%
Valvular disease 8%
Kidney damage-light 16%
Kidney damage-mild 51%
Kidney damage-moderate 30%
Kidney damage-severe 3%
Congestive heart failure 19%
Ischemic heart disease 21%
Medication prescribed
Insulin 13%
Sulfonylureas 17%
Hypoglycemics 16%
Other 54%
The majority of BP records before 2007 in our dataset tend to be missing. Hence, the miss-
ingness percentages of these time-varying covariates are all above 50%, similar to those of
A1c values.
Missing data in the time-varying covariates cause computational problems, and here we
only consider missing A1c values and include other variables that are fully collected. The
extension to handle missing values in the baseline and time-varying variables and perform
a systematic variable selection by propagating all sources of uncertainty is discussed in
Section 6.
3 Bayesian profiling multiple imputation
Denote the individual record for patient i by {Xi0,Xij, Yij, Rij, j ∈ [1, Ti]} for the total
number Ti of tracked quarters during the follow-up, where Xi0 are the time-invariant co-
variates, Xij’s are time-varying covariates, and Yij is the variable to be imputed, A1c values
over time. For brevity, we will refer to Yij as the longitudinal outcome. Assume that only
Yij’s are subject to missing values, and let Rij be a time-varying binary indicator for its
response, Rij = 1 if Yij is observed, Rij = 0 otherwise. Denote the time-varying variables by
Yi = (Yi1, . . . , YiTi)
ᵀ, Xi = (Xi1, . . . ,XiTi)
ᵀ, and Ri = (Ri1, . . . , RiTi)
ᵀ, for i = 1, . . . , n total
number of patients.
Assume individuals fall into latent classes Ci = 1, . . . , L, where L is a finite and positive
known integer as the total number of classes. The selection of L and the case of L being
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an unknown random variable that induces additional uncertainty are discussed in Section 5
and Section 6. We assume that the latent class structure is primarily determined by the
trajectories of the longitudinal outcome and potentially its missingness pattern, and that
the allocation probabilities are affected by the covariates.
The conditional distribution of the measurements given observed data can be expressed
as
f(Yi|Xi0,Xi,Ri = 1) =
L∑
l=1
f(Ri = 1|Yi,Xi0,Xi, Ci = l)f(Yi|Xi0,Xi, Ci = l)f(Ci = l|Xi0,Xi)
f(Ri = 1|Xi0,Xi) ,
where f(·) denotes the distribution.
If Ri only depends on fully observed (Xi0,Xi), i.e., missingness is MAR, the observed
data can provide valid inference since f(Yi|Xi0,Xi,Ri = 1) = f(Yi|Xi0,Xi). The profile
structure is then independent of the missingness patterns.
f(Yi|Xi0,Xi,Ri = 1) =
L∑
l=1
f(Yi|Xi0,Xi, Ci = l)f(Ci = l|Xi0,Xi).
We call this marginal profiling because the latent class structure influences only the
marginal distribution of Y . The MAR assumption can be relaxed to
f(Ri = 1|Yi,Xi0,Xi, Ci = l) = f(Ri = 1|Xi0,Xi, Ci = l), (3.1)
that is, conditional MAR, where the missingness is independent of the outcome given the
latent classes and covariates. However, the unconditional missingness is nonignorable as the
latent structure affects both the longitudinal outcome and missingness patterns. Joint mod-
eling of (Yi,Ri) is then necessary and will be identified due to the conditional independence
assumption given the latent classes. We call this approach joint profiling.
Joint profiling is identical to marginal profiling when the parameters in Model (3.1) do
not change across profiles, so Ri is conditionally independent of Ci given (Xi0,Xi). Hence,
the joint profiling approach can model both ignorable and nonignorable missing data. We
will consider both the marginal and joint profiling for imputation and make inferences on
the effect of A1c levels on acute health outcomes.
The latent classes are at the individual level and thus time invariant. Further, we as-
sume the latent class allocation depends only on time-invariant variables f(Ci = l|Xi0,Xi) =
f(Ci = l|Xi0). For computational and interpretational convenience, we assume that the out-
come trajectory is independent of time-invariant covariates given the latent class f(Yi|Xi,Xi0, Ci =
l) = f(Yi|Xi, Ci = l). That implies that the patient characteristics at baseline are repre-
sented by the latent profiling.
Here, the conditional independence assumption between Yij and Rij given Ci is used
for identification, and the conditional independence assumptions involving Xi0 and Xij are
introduced for interpretation and can be tested in the model fitting.
Are our assumptions regarding the missing data too strong? Haneuse and Daniels (2016)
list various sub-mechanisms—potentially MAR or MNAR—that are relevant to missing
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EHRs, such as enrollment status, encounters with the health system, measurements and
structural changes. McCulloch et al. (2016) evaluate biased and unbiased estimation in
longitudinal studies with informative missingness and recommend mixed-effects models. In
addition to random effects, we introduce latent profiles with a large number of covariates,
and expect the flexible latent profiling with rich characteristics to capture the underlying het-
erogeneity and make the assumptions at least plausible. We rigorously assess the imputation
performances in Section 5.
3.1 Marginal profiling
Under MAR we construct latent profile models based on the collected outcomes, i.e., marginal
profiling, which is estimated from the pattern of trajectories of the longitudinal outcomes.
f(Y obsi |Xi0,Xi) =
L∑
l=1
f(Y obsi |Xi, Ci = l)f(Ci = l|Xi0). (3.2)
Here Y obsi denotes the observed A1c measurement for individual i. The factorization involves
an outcome model and a latent profile model. The model specification in (3.2) assumes: 1)
the missingness pattern is independent of the A1c values and the latent profiles given the
covariates Rij ⊥ (Yij, Ci)|(Xi0,Xij); 2) the A1c values are independent of the missingness
patterns and the baseline characteristics given the latent profiles and time-varying covari-
ates Yij ⊥ (Rij,Xi0)|(Ci,Xij); and 3) the latent profiles are independent of the time-varying
covariates given the baseline characteristics Ci ⊥ Xij|Xi0. Since the role of Xi0 can be
checked, Model (3.2) can be generalized by assuming the outcome depends on the baseline
characteristics and that these are captured by the latent profiling in the current specification.
Our sensitivity analysis in the EHR application does not find evidence against the specifi-
cation with Xi0, as the covariates affect the allocation assignment probability of different
profiles.
In the latent profile model, denote by f(Ci = l|Xi0) .= pil(Xi0) the allocation probability
of pattern l conditional onXi0, for l = 1, . . . , L. We consider a multinomial logistic regression
model with coefficient vector ηl, for l = 1, . . . , L. Set η = (η1, . . . ,ηL) and η1 = ~0 for
identification, we have
pil(Xi0) =
exp(XTi0ηl)∑L
k=1 exp(X
T
i0ηk)
. (3.3)
For posterior computation we develop a Gibbs sampler by introducing Po´lya-Gamma
(PG) distributed variables wil (Polson et al. 2013),
wil|(Xi0,η) ∼ PG(1, ril),
where ril = X
T
i0ηl − log[
∑
k 6=l exp(X
T
i0ηk)]. Conditional on the PG variables, the posterior
distribution of ηl will be conjugate with normal prior distributions. The resulting Gibbs
9
sampler improves the posterior fitting and outperforms rejection sampling methods with
quick convergence.
Let cil = I(Ci = l) be the latent class indicator and introduce the normal prior distribu-
tion N(bl,Bl) on the coefficients ηl, the conditional posterior distribution of ηl given w is
multivariate normal, pi(ηl | −) ∼ N(m∗l ,S∗l ). Here S∗l = (VTΩlV + B−1l )−1, V is the design
matrix with each row XTi0, Ωl = diag(w1l, . . . , wnl), and m
∗
l = S
∗
l (B
−1
l bl + S
Tml), where ml
is a vector in Rn, and the ith component is m
(i)
l = cil − 1/2 + wil{log[
∑
k 6=l exp(X
T
i0ηk)]}.
For the collected longitudinal and continuous A1c measurements, we assume a linear
mixed-effects model with profile-specific coefficients and variances (β∗C , σ
2
C). Let Di denote
a Ti × p covariate matrix, with associated p-vector of coefficients β. The jth row of Di,
denoted by Dij, is then a p-vector of covariate values measured at time j. Covariates for
profile-specific effects β∗Ci and for individual-specific random effects bi are denoted by the
Ti × q matrix D∗i and the Ti × r matrix D∗∗i , respectively, both with structures similar to
Di. There may be overlap of the covariates in Di, D
∗
i and D
∗∗
i , including main effects
and high-order interactions of Xi. Deterministic functions of time, for example, basis spline
functions of time in our EHR application, can be included in the covariates.
Yi = Diβ +D
∗
iβ
∗
Ci
+D∗∗i bi + i (3.4)
bi ∼ N(~0,Σr×r), and i ∼ N(~0, σ2CiITi×Ti),
which is a linear mixed-effects model with a mixture of location and scale parameters varying
across profiles. The profile-specific coefficients β∗Ci can capture the differential trajectories
of A1c measurements with time-varying covariates in D∗i . Model (3.4) is a location and
scale mixture model that is flexible enough to capture non-Gaussian distributions as shown
in Figure 2.1. Here Σr×r is the covariance-variance matrix of the individual-specific random
effects bi, which could be simplified as a diagonal matrix if the components of bi are treated
as independent or a scalar if bi only represents random intercepts.
We assign weakly informative and conjugate prior distributions to the parameters (Gel-
man et al. 2008). The prior specification and full conditional posterior distributions as
efficient Gibbs sampler are presented in Appendix B.1. After convergence, based on the
posterior samples of the parameters, we can impute the missing A1c values and disseminate
completed datasets.
3.2 Joint profiling
With MNAR, we jointly model the A1c values and missingness patterns given the covariates
to obtain the joint profiling structure
f(Yi,Ri|Xi0,Xi) =
L∑
l=1
f(Yi|Xi, Ci = l)f(Ri|Xi, Ci = l)f(Ci = l|Xi0), (3.5)
where Yi includes both observed and missing measurements. The joint model has three
components: the latent profile model, the longitudinal outcome model and the longitudinal
response propensity model.
10
This model captures the MNAR dependence between the outcome and missingness pat-
terns that jointly determine the latent profiles. The response indicator is conditionally
independent of the outcome given the latent profiles and covariates, i.e., conditional MAR:
Rij ⊥ (Yij,Xi0)|(Ci,Xij). Conditional MAR makes models identifiable, yet flexible for
dimension reduction and interpretation.
We consider a generalized linear mixed-effects model with a logit link for the longitudinal
response indicator Rij, conditional on latent classes and random effects ei ∼ N(0,E) with
E as a covariance-variance matrix.
logitPr(Rij = 1|Xij, Ci, ei)) = Dijα+D∗ijα∗Ci +D∗∗ij ei, (3.6)
where the covariates (Dij,D
∗
ij,D
∗∗
ij ) could overlap or be different from those selected in
Model (3.4) as subsets of the main effects and high-order interactions in Xij.
3.3 Summary
The full model specification under marginal profiling is summarized below:
Yi ∼ N(Diβ +D∗iβ∗Ci +D∗∗i bi, σ2CiITi×Ti) (3.7)
Ci ∼ Multinomial(pi1(Xi0), . . . , piL(Xi0))
pil(Xi0) =
exp(XTi0ηl)∑L
k=1 exp(X
T
i0ηk)
bi ∼ N(~0,Σr×r), β ∼ N(0,Σβ), Σr×r ∼ Inverse-Wishart(νb,Σb)
σ2l ∼ Inverse-Gamma(a, b), ηl ∼ N(bl, Bl), for l = 1, . . . , L.
The full model specification under joint profiling is summarized below:
Yi ∼ N(Diβ +D∗iβ∗Ci +D∗∗i bi, σ2CiITi×Ti) (3.8)
Rij ∼ Bernoulli(Pr(Rij = 1))
Inverse-logit(Pr(Rij = 1)) = Dijα+D
∗
ijα
∗
Ci
+D∗∗ij ei
Ci ∼ Multinomial(pi1(Xi0), . . . , piL(Xi0))
pil(Xi0) =
exp(XTi0ηl)∑L
k=1 exp(X
T
i0ηk)
bi ∼ N(~0,Σr×r), β ∼ N(0,Σβ), Σr×r ∼ Inverse-Wishart(νb,Σb)
αl ∼ N(0,Σα), ηl ∼ N(bl, Bl), σ2l ∼ Inverse-Gamma(a, b),
ν ∼ N(0,Σν), γl ∼ N(0,Σγ), ei ∼ N(0,E), E ∼ Inverse-Wishart(νe,Σe).
We set the hyper-parameters equal to 1 and specify an independent covariance matrix
structure. Our inference is not sensitive to the specification of hyper-parameter values (e.g.,
0.1, 0.01) under noninformative or weakly informative prior settings, as expected given the
large sample sizes in the application. The PG variables wil’s are introduced for posterior
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updating with η. We develop the Gibbs sampler with two sets of introduced Po´lya-Gamma
distributed variables for posterior computation with models (3.3), (3.4) and (3.6) under
weakly informative and conjugate prior distributions. The imputation of missing A1c values
is nested in the iterative process, unlike marginal profiling, where parameter estimation and
data augmentation are implemented simultaneously. Computational details are presented in
Appendix B.2.
For ease of interpretation of the potential profiling structure, we fix the number of latent
patterns L to be a small integer, chosen with the aid of diagnostic tools for model selection
described in Section 5.1. The model can be extended to allow nonparametric Bayesian
modeling, such as the dependent probit stick-breaking process (Rodr´ıguez and Dunson 2011).
However, discrete covariates with low prevalence tend to cause separation problems with a
large number of latent profiles, as in our application study.
The BPMI in (3.7) and (3.8) uses mixture models to flexibly capture irregular distribu-
tions, incorporate time trends, and latent profiles allow us to jointly model the outcomes
and nonignorable missingness patterns.
4 Simulation
We evaluate the imputation quality and MI inferential validity in repeated sampling. We
simulate unbalanced longitudinal data, and the outcome is subject to intermittent missing
values. For each sample, we generate n = 500 subjects with varying lengths of follow-up
periods Ti’s randomly selected from {1, . . . , 10} and time-invariant covariates Di with four
binary indicators simulated from Bernoulli’s distributions with probabilities 0.2, 0.3, 0.4, and
0.5, respectively. The time-varying covariate is the time after the first collection, where we
use tij denoting the time points of collection divided by 4 to mimic the quarter structure in
the EHR data. We consider different outcome generation models and different missingness
mechanisms, as we now describe.
In Case 1, we groups the 500 subjects into L = 3 classes with allocation probabilities
exp(Diηl)/(1 + exp(Diηl)), where η1 = ~0, ηl = 0.5 ∗ (1 : 5) − 0.5 ∗ l, for l = 2, 3. The
outcome Y is simulated from a 3-component finite mixture of normal distributions with mean
µij = bi + Diβ0 + tijβ1l + t
2
ijβ2l and standard deviation (sd) σl, for l = 1, 2, 3, respectively.
Here we set β0 = (2, 2, 2, 2, 2), β11 = 0, β12 = −2, β13 = 2, β21 = 0, β22 = 1, β13 = 1, σ1 =
0.1, σ2 = 1, and σ3 = 3. We assume the intermittent missingness is MAR with the response
probability Pr(Rij = 1) = exp(Diα0 + tij)/(1 + exp(Diα0 + tij)) for j = 2, . . . , Ti, i = 1, . . . n,
where α0 = (−2,−1, 0, 1, 2). The missingness mechanism depends on the main effects of the
covariates and time. The missingness proportion is around 38%. The data generation and
missingness mechanism in Case 1 are consistent with the outcome models and identification
assumptions under marginal profiling, denoted as Mixture–Main.
In Case 2, the outcome is simulated from a normal distribution with mean µij = bi +
Ditijβ0 + tijβ1 and sd=1, where the interaction term between the time-invariant covariates
and time are included with β0 = (2, 2, 2, 2, 2) and β1 = 1. The model assumes that the linear
trends vary across individuals. The missingness mechanism is the same as that in Case 1.
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We denote the data generation and missingness mechanism in Case 2 as Interaction–Main,
which differs from the outcome model assumptions under BPMI.
In Case 3, the outcome model has the same specification as that in Case 2, with interaction
terms. The missingness also depends on the interaction terms between the time-invariant
covariates and time: Pr(Rij = 1) = exp(ei + Diα0 + tijα1 + Ditijα2)/(1 + exp(ei + Diα0 +
tijα1 + Ditijα2)) for j = 2, . . . , Ti, i = 1, . . . n, where α0 = (1, 1, 1, 1, 1), α1 = −0.5, α2 =
(−2,−1, 0, 1, 2), and eij ∼ N(0, 1), with resulted missingness around 20%. We denote the
data generation and missingness mechanism in Case 4 as Interaction–Interaction, which
differs from assumptions for both the outcome and missingness mechanism under BPMI.
In Case 4, the outcome model is the same as that in Case 1. We assume that the
missingness depends on the group structure, and it is conditionally MAR but marginally
MNAR. The response probability is Pr(Rij = 1) = exp(ei + Diα0 + tijα1l + t
2
ijα2l)/(1 +
exp(ei +Diα0 + tijα1l + t
2
ijα2l)) for j = 2, . . . , Ti, i = 1, . . . n, where α0 = (1, 1, 1, 1, 1), α11 =
0, α12 = −2, α13 = 2, α21 = 0, α22 = −4, α23 = 4, and eij ∼ N(0, 1), resulting in around 35%
of missing values. The scenario in Case 3 is similar to that under joint profiling, denoted as
Mixture–Mixture.
In Case 5, we violate the conditional MAR assumption by specifying the response propen-
sity still depends on the outcome given the group structure. The remaining specifications
are the same as those in Case 4. This case is denoted as Mixture–Outcome.
We implement the marginal profiling approach (BPMI-MAR), the joint profiling ap-
proach (BPMI-MNAR), with the popular imputation methods MICE and multilevel impu-
tation MICE-2l, to generate 10 imputed datasets each. Both MICE and MICE-2l assume
MAR. MICE treats measures at the 10 time points as 10 different variables, performs fully
conditional chained imputation with linear regression models and fills in missing values with
draws from observed cases based on predictive mean matching by default. This accounts
flexibly for the correlation between repeated measures but ignores any pattern across time.
MICE generates balanced data, where measures at all time occasions are filled in even though
some are not eligible in the intrinsic data structure. MICE-2l fits a multilevel model for the
outcome with a random intercept and a random slope for time. MICE-2l fits a linear time
trend, and assumes normality of all random components. Hence, BPMI differs from the
other two approaches in being able to handle MNAR, having more flexible distributional
assumptions, modeling the time trend in a flexible manner and in handling covariates in an
implicit manner with potential interaction terms rather than by an explicit inclusion of main
effects.
We run BPMI-MAR in the exact specification in (3.7) for 3000 iterations and BPMI-
MNAR in (3.8) for 2000 iterations with L = 3. The time-varying covariates in BPMI include
the basis spline functions of time used in Section 5 and given in Appendix A. Our quantities
of interest are the average values of the outcome in the follow-up period, across j = 2, . . . , 10.
We perform repeated sampling for 100 times and stack the generated samples treated as the
population. We combine the MI inferences and calculate average values of the bias, root
mean squared error (RMSE) and nominal coverage rate of 95% confidence intervals for each
of these four approaches. We divide the bias and RMSE by the true value and present the
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relative bias (Rel–Bias) and relative RMSE (Rel–RMSE), and coverage rates in Figure 4.1.
The marginal profiling approach is the most robust and efficient method across the five
cases. In Case 1, the sequential imputation MICE generates unbiased estimates but with
larger RMSEs and smaller coverage rates than the BPMI-MAR. The performance of joint
profiling BPMI-MNAR is competitive, with relatively larger bias and RMSE but negligible
differences. The coverage rates of multilevel imputation models MICE-2l are generally lower
than 0.95 even with large RMSEs.
Case 2 shows that BPMI can recover the interaction effects through latent profiling when
the covariates enter through the allocation probabilities but are excluded in the outcome
modeling and imputation. This is also confirmed in Case 3, when interaction terms are
present in the response propensity model. In Case 4, with marginal MNAR and conditional
MAR, MICE and MICE-2l fail to yield valid inferences as both methods assume MAR.
The BPMI approaches outperform with small bias, RMSEs and reasonable coverage rates.
The outputs of joint profiling BPMI-MNAR did not show improvement over those under
marginal profiling. This could be due to the Monte Carlo error with not enough number of
repeated samples or the computation problems of BPMI-MNAR that requires more iterations
to converge. Both BPMI and MICE generate large biases and RMSEs in Case 5, when the
missing data mechanism assumption is violated.
5 Imputation and Inference with EHRs
In a two-step MI process, we first apply BPMI to impute missing A1c values in the EHRs
and secondly make inference on how A1c relates to acute diabetes outcomes. The observed
A1c values range from 3.3% to 17.3% with mean 7.1% and are right-skewed with multiple
modes. We use the location and scale mixture distribution as a flexible strategy to capture
the irregular distribution. In the profile allocation model (3.3), the time-invariant covariates
Xi0 are the baseline characteristics listed in Table 2.1. In the A1c outcome and response
propensity models (3.4) and (3.6), the covariates inDij with fixed effects include the constant
ones and the time-varying variables, age and the count of physician visits. The covariates
in D∗ij represent the functions of time in years with slopes changing across classes. We use
the basis spline functions of time with (1%, 15%, 20%, 50%, 75%, 90%) quantiles as six knots
and cubic terms as a piecewise polynomial regression, and the nine spline functions used
as covariates in D∗ij with profile-specific coefficients as shown in Appendix A. The spline
functions are chosen based on model fitting criteria and can handle complex shapes to create
smooth curves. Details on diagnostics of model specifications are provided in Section 5.1.
Random intercepts are introduced by D∗∗ij .
To set up the initial values of the Markov chain Monte Carlo (MCMC) updating, we fit
an ordinary linear regression and use the coefficient estimates as initial values for β and β∗l ’s
whose starting points are the same across classes. The initial values of η’s are ~0, representing
an initial equal probability of class allocation. The scale parameters start at 0.1, and the
random effects are initially drawn from normal distributions with mean 0 and the initial
scales.
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(a) Case 1: Mixture–Main.
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(b) Case 2: Interaction–Main.
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(c) Case 3: Interaction–Interaction.
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(d) Case 4: Mixture–Mixture.
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(e) Case 5: Mixture–Outcome.
Figure 4.1: Performance of MI inferences on the average outcome values at 9 follow-up occa-
sions with 10 imputed datasets comparing different approaches: marginal profiling (BPMI-
MAR), joint profiling (BPMI-MNAR), sequential imputation MICE and multilevel imputa-
tion MICE-2l.
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Table 5.1: Comparison of models with different number of profiles (L).
Marginal profiling Joint profiling
L BIC LPML L BIC LPML
2 126857 -106129 2 323529 -192506
3 124145 -94305 3 329037 -174286
4 130872 -97579 4 334345 -180697
5 136263 -97315
6 137082 -97397
We implement posterior computation for both marginal and joint profiling. The MCMC
algorithms efficiently achieve convergence with Gibbs samplers as diagnosed by trace-plots
of the posterior samples, where 15000 iterations under marginal profiling and 5000 iterations
under joint profiling take ∼5 hours to finish each with R codes run on a standard laptop
(3.5 GHz Dual-Core Intel Core i7, 16 GB Memory), and the computational speed can be
substantively improved with R–C++ interface and parallel computing resources. We run
the MCMC chains long enough to obtain 100 multiply imputed datasets and 500 replicated
datasets to check if imputation is able to predict observed outcomes. For classification, we
follow Goodman (2007) with a hard partitioning and keep one random assignment based
on a random draw from the component-specific probabilities across iterations. Our analysis
shows that the results are not sensitive to the classification rules.
5.1 Model diagnostics and comparison
We use the Bayesian information criterion (BIC) and the log-pseudo marginal likelihood
(LPML) to select the number of classes, L. For BIC, we use the posterior mean estimates
of related parameters and obtain the likelihood conditional on the class allocation. LPML
is the sum of logarithms of conditional predictive ordinates and estimated using posterior
samples of parameters, θ(t), t = 1, . . . , T , and LPML=[1/T
∑T
t=1 1/f(Yi|θ(t))]−1 (Gelfand and
Dey 1994). This is an approximation of the leave-one-out cross-validation using importance
sampling. We use f(Yi|θ(t)) for the marginal profiling and f(Yi, Ri|θ(t)) for the joint profiling.
We restrict L to be small to avoid computational problems due to the separation of the
low-frequency predictors, such as dementia and renal failure. Table 5.1 presents the BIC
and LPML values for models with different L values. The model with the smallest BIC
and largest LPML will be favored. We see that the model with L = 3 classes presents a
reasonable choice both for marginal and joint profiling.
To assess whether imputations are plausible, we perform a posterior predictive check and
generate replicated datasets that are predicted values of observations based on the posterior
estimates of model parameters after convergence (Meng 1994). Let {R(1), . . . , R(T 0)} be the
collection of the T 0 replicated data sets. We then compare statistics of interest in each
replicated dataset to those in the observed dataset D. Suppose that S is some statistic of
interest, let SR(t) and SD be the values of S computed from R
(t) and D, respectively. The
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quantities S include the mean, 2.5% percentile and 97.5% percentile of A1c levels for every
patient and for every quarter. For the patient-level summaries, we look at the two-sided
posterior predictive probabilities as diagnostic tools defined as
ppp =
2
T 0
∗min(
T 0∑
t=1
I(SR(t) − SD > 0),
T 0∑
t=1
I(SR(t) − SD < 0)).
When the value ppp is small, for example, less than 5%, this suggests that the replicated data
sets systematically differ from the observed data set, with respect to that statistic. With
larger ppp values, the evidence does not contradict that the imputation model preserves
the observed characteristics of that statistic (He et al. 2010; Si et al. 2016). For the 7372
patient-level A1c summaries, the marginal profiling model yields 52 ppp values that are
below 1% for the average, and the numbers of below 1% ppp values for the 2.5% percentile
and the 97.5% percentile are 238 and 375. The number of ppp values that are below 1%
for these three statistics under joint profiling is 66, 464 and 678, respectively. Based on the
low proportions of small ppp values, the posterior predictive check does not indicate lack
of model fit in recovering the trajectories. However, the performance of joint profiling is
inferior to marginal profiling in preserving the observed mean values across patients.
For the quarter-level A1c summaries, we compare the predictions with the observed
values under the two profiling approaches. The 95% predictive credible intervals greatly
overlap with the empirical 95% confidence intervals (CIs). Figure 5.1 shows that the poste-
rior predictive mean estimates are generally close to the observed mean values, except for
two observations, and both approaches perform competitively and similarly. We check the
parameter estimates in Model 3.1, and find that the coefficients do not change across profiles.
This explains the similar performance of joint profiling and marginal profiling.
We also compare BPMI with MICE and MICE-2l, by examining the summaries of the
imputed A1c values. Figure 5.2 depicts the average values and 95% confidence intervals of
A1c measurements in the follow-up period from the 5th to the 44th quarter. We do not have
a gold standard for the missing values and aim to check which method can recover the data
structure. With the MAR assumption for MICE and BPMI under marginal profiling, the
time dependence structure should be the same between the imputed data and observed data.
Comparing the trajectories of the imputed data to those of the observed data in Figure 5.1,
marginal profiling under BPMI yields imputation that presents the patterns most similar to
the observed data, showing the trend of BPMI first flat and then increasing. The failure
of MICE to impose a time structure results in wiggly averages and the last measurement
having the lowest value. In addition, the need for MICE to impute occasions post drop-out
or death may have led to inconsistent means in the later quarters. The multilevel imputation
MICE-2l smooths the variation across time and presents a linear trend, which is different
from the observed trends in Figure 5.1. Both MICE approaches tend to generate larger
imputed values than those under BPMI, potentially due to the ability of BPMI to better
replicate a multimodal skewed distribution of A1c values.
In fact, BPMI imputes a substantially higher proportion of A1c values in the 6-7% range
and fewer in the 7-8% range or below 6% than do MICE or MICE-2l. Based on a randomly
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Figure 5.1: Posterior predictive check on quarter-level summaries for marginal and joint
profiling approaches. The black triangles represent the means of observed data, the red dots
are the posterior predictive mean estimates, and the red error bars are the 95% credible
intervals of the predictive means.
selected single imputed dataset, 18.3% of the imputed values from BLPM are below 6%,
44% values are between 6% and 7%, and 23% values are in the 7-8% range. However, the
imputed values from MICE have 20% below 6%, 37% between 6% and 7%, and 27% in the
7-8% range, and the percentages from MICE-2l are 21%, 36% and 28%, respectively. Having
more imputed data in the below 7% range resonates clinically with the fact that patients in
that range have met ADA goals and may be seen as needing less frequent A1c testing.
5.2 Inference and profiling
After MI, we analyze the completed datasets to evaluate the association of A1c with acute
health event incidence and depict the different trajectories of A1c values across time indicated
by the profiling structure.
5.2.1 Association of A1c with acute adverse events
We aim to address whether using imputed data affects inferences on how glycemic control
is associated with acute diabetes outcomes. Since marginal profiling and joint profiling
present similar results, we use the results under marginal profiling as an illustration. It
should be noted that the MAR assumption here applies to missing A1c. The complete case
analysis (CCA) applies to the occasions with collected A1c values and causes exclusion of
the outcomes available at the occasions where A1c values are missing. Hence, missingness
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Figure 5.2: Comparison of the average of imputed A1c values and 95% confidence intervals
obtained by BPMI, MICE and MICE-2l across follow-up quarters. The wide CI of the MICE
output for the last quarter (6.11, 7.40) is omitted.
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in the outcome is induced by missing A1c and may be MAR or MNAR, but imputing A1c
restores all the outcomes.
The overall incidence of any acute health events is 16% across the patient-quarters. We
predict this incidence by a seven-category discrete A1c indicator (< 6%–reference level, 6−
6.5%, 6.5−7%, 7−7.5%, 7.5−8%, 8−9%,≥ 9%), where the levels are chosen to coincide with
those used by ADA to translate A1c into blood glucose level (ADA 2018a). For simplicity,
we do not add other factors. For each imputation, we estimate the incidence from logistic
regression models and account for the correlation between repeated measures of the same
patient by implementing generalized estimating equations with an exchangeable working
correlation structure. We apply MI combining rules (Rubin 1987) to obtain the standard
error estimate accounting for the uncertainty due to imputation. Figure 5.3 depicts the pre-
dicted incidence for individuals grouped by A1c levels from the four methods, and Table 5.2
presents both the point estimates and 95% CIs of the predictions. Figure 5.3 shows that the
relationship between A1c values and the risk of adverse outcomes is U-shaped.
Importantly, all analyses verify that A1c at or above 8% is associated with a higher
incidence of adverse events than levels of 6-7.5% as expected from ADA recommendations
to maintain level below 7% or below 6.5%, if possible. In fact, imputation does not notably
change means for the two categories above 8%, where less than 10% of A1c values are
imputed. Results for levels < 6%, where approximately 20% of values are imputed, are
mixed, with BPMI as well as CCA showing a significantly higher incidence of acute events
at this level of control than for A1c levels 6-7. 5%. While MICE and MICE-2l also show
higher incidence at A1c< 6% than at the next two higher levels, these differences are not
statistically significant.
Table 5.2: Predictive acute health event incidence risk and 95% confidence intervals for
individuals grouped by A1c levels.
BPMI MICE MICE-2l CCA
< 6% 0.174 (0.164, 0.182) 0.168 (0.16, 0.177) 0.169 (0.161, 0.178) 0.175 (0.164, 0.187)
6− 6.5% 0.162 (0.156, 0.169) 0.164 (0.157, 0.169) 0.164 (0.157, 0.171) 0.157 (0.149, 0.164)
6.5− 7% 0.161 (0.154, 0.168) 0.164 (0.157, 0.169) 0.164 (0.157, 0.169) 0.154 (0.147, 0.161)
7− 7.5% 0.164 (0.157, 0.172) 0.165 (0.158, 0.172) 0.165 (0.158, 0.172) 0.157 (0.149, 0.165)
7.5− 8% 0.165 (0.157, 0.175) 0.167 (0.157, 0.175) 0.165 (0.156, 0.174) 0.155 (0.146, 0.165)
8− 9% 0.178 (0.169, 0.187) 0.178 (0.169, 0.187) 0.177 (0.167, 0.185) 0.175 (0.164, 0.185)
9%+ 0.193 (0.179, 0.206) 0.192 (0.179, 0.206) 0.192 (0.179, 0.206) 0.196 (0.182, 0.211)
The incidence between A1c of 6% and 8% shows the largest differences between CCA
and analyses with imputed data. MICE and MICE-2l agree with BPMI in showing higher
incidence than CCA in this range, but BPMI shows a slightly lower incidence than the
other two methods, indicating that BPMI tends to place more low risk individuals in this
category. The evidence from BPMI is similar to the finding in Li et al. (2019). The fact
that all methods show higher incidence than CCA in this range may be due to a complex
interplay of reasons for missed A1c tests and their consequences, where missed A1c may be
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Figure 5.3: Comparison between MI inferences and complete case analysis (CCA) in predic-
tive acute health event incidence risk.
a marker for either good and stable glycemic control, or for lower utilization of preventive
care. Future work will study the heterogeneous effects of patent complexity in the nonlinear
relationship.
It seems that the probability of missingness depends on the outcome in this example, so
that the missingness induced by A1c is MNAR in the acute event model. However, it is less
clear if explicitly taking the outcome into account would change the relationship between
imputed A1c and the outcome. Doing so would require specifying a correct model for the
relationship between A1c and the outcome. Including the outcome as a covariate with main
effects in MICE-2l, made no difference in predictions. We posit that imputing the A1c from a
rich set of repeated measures for each individual minimizes the information the outcome can
bring to the imputation. It should also be noted that baseline event incidence was included
as a covariate in the imputation.
5.2.2 Profiling heterogeneity and interpretation
As one important byproduct of BPMI, the latent profiling provides an interpretable summary
of patient heterogeneity in A1c trajectories. As an illustration, we randomly draw the latent
class indicators based on the posterior allocation probabilities and use the last draw for the
profiling assignment. The three profiles have different trajectories over time and different
scales. Figure 5.4 shows the estimated spline functions and 95% CIs, as well as the observed
A1c values across profiles. We present the two plots in Figure 5.4 to illustrate the profiling
structure, but they are not directly comparable. The spline functions (D∗iβ
∗
Ci
) are part of the
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Figure 5.4: Estimated spline functions with 95% confidence intervals and observed A1c values
of patients across profiles.
mean structure, so the two plots have different y-axis ranges. Meanwhile, we have included
additional time-varying variables, and they both have significantly positive relationships with
A1c values, where the coefficient estimate of age is 0.007 with 95% CI (0.006, 0.008), and
the coefficient estimate of the count of physician visits is 0.003 with 95% CI (0.001, 0.006).
The profile allocation assigns 3694 patients to the largest class with the smallest variabil-
ity of residuals, 0.29. The smallest class has 996 patients and the largest variability of A1c
values (1.42), with large coefficients of the spline functions. The remaining class has 2692
patients, and the estimated variability of A1c values is 0.65. The patients within Profile 1
are under good control with low A1c levels and stability, of whom all the A1c values are
below 9%. Patients within Profile 2 are under fair control with modest A1c values, while
those with Profile 3 are under bad control with high A1c levels and variability.
The profiling is primarily dependent on the A1c trajectories, and the profile allocation
probabilities are predicted by the baseline covariates. Figure 5.5 and Table 5.3 provide the
descriptive summary of the baseline characteristics and the corresponding coefficients for
profile allocation. The patients in poor control in Profile 3 tend to be non-white, have
Medicaid coverage and more complications (such as Depression, Entitlement Disability, Eye
disease, Psychoses and Obesity), and take Insulin. These patients also have more ER visits,
more adverse events, higher HCC and baseline A1c values than those in good/fair control.
The coefficients for allocation across profiles give the logarithm of the relative odds to be
assigned to other profiles compared to Profile 1. With higher baseline HCC and A1c values,
the patients tend to be out of good control. Non-white patients with Chronic Pulmonary
Disease, Entitlement Disability, other neurological disorders, Obesity, Psychoses and taking
the hypoglycemic drug, have significantly higher odds of being out of good control. The
patients with Dementia, Eye disease, congestive heart failure and those who take Insulin or
Sulfonylureas tend to have good A1c control.
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Table 5.3: Descriptive statistics of baseline characteristics (first 4 quarters) and their coeffi-
cients for allocation across profiles.
Profile 1 Profile 2 Profile 3
Descriptive statistics: mean (sd)
#low prevalence 0.22 (0.54) 0.21 (0.54) 0.21 (0.54)
#ER visits 0.11 (0.39) 0.10 (0.29) 0.17 (0.45)
#Adverse events 0.54 (0.85) 0.57 (0.86) 0.73 (0.97)
HCC 1.26 (0.84) 1.57 (1.11) 1.57 (1.01)
Age 71.52 (9.98) 69.76 (10.28) 64.33 (12.73)
A1c 6.38 (0.63) 7.23 (0.93) 8.5 (1.66)
Coefficients: log-odds (95% CI)
Intercept 0 -6.08 (-7.51, -4.94) -9.15 (-10.29, -8.01)
#low prevalence 0 -0.34 (-0.52, -0.16) -0.44 (-0.68, -0.21)
#ER visits 0 -0.46 (-0.81, -0.13) -0.41 (-0.79, -0.05)
#Adverse events 0 0.12 (-0.01, 0.25) 0.15 (-0.02, 0.32)
HCC 0 0.58 (0.36, 0.73) 0.59 (0.36, 0.76)
Age 0 -0.06 (-0.07, -0.04) -0.11 (-0.12, -0.09)
Baseline A1c 0 1.35 (1.25, 1.46) 2.06 (1.92, 2.19)
6 Discussion
Electronic health records play an increasingly important role in evidence-driven research on
effective approaches to clinical therapy. However, as data are collected in an unstructured
manner when patient contacts occur, EHR suffers from missing data, where for example, out-
comes and predictors are not always available in the same time interval. MI is an attractive
approach for filling in data needed for various analyses, allowing assessment of imputation
uncertainty. However, few methods exist for filling in intermittently missing data in long
time sequences. In addition, the missing mechanism is often complex raising the possibility
of informative missingness. We develop a method for multiple imputation based on Bayesian
latent profiling, which allows for missingness being intermittent and potentially MNAR. The
method allows for a flexible mixture distribution by allowing location and scale parameters
to vary across latent profiles, covariates to predict profile membership and a time trend to
be modeled by splines. We compare BPMI with popular MI MAR based approaches MICE
and MICE-2l by simulations in a range of settings, and find BPMI to be the most unbiased
and efficient. We apply our method to missing A1c in EHRs, and find BPMI to perform
well with 3 latent classes, in terms of BIC, LPML and posterior predictive checks. Hence,
the theoretical properties for our approach seem to be satisfactory.
As we predict acute adverse outcomes from the EHR with and without imputation, BPMI
as well as MICE and MICE-2l predicts more adverse events than does CCA in the 7-8% A1c
range. Hence, CCA analysis of the EHR data cannot be trusted. While a MAR structure
fits the A1c data, it appears that the missingness induced in the outcome by missing A1c is
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Figure 5.5: Frequency distribution of categorical baseline characteristics and their coefficients
for profile allocation.
not MAR. However, all outcomes are restored when A1c is imputed. Our future work will
explore including the acute outcomes in the imputation as generally recommended. However,
it is unclear how much this would change the imputed values given the availability of rich
A1c trajectories and many covariates. It is also challenging to specify the model to properly
account for the non-linear relationship and patient heterogeneity. Our approach avoids the
need to model the dependence of the outcome on A1c, and improves the availability of the
A1c values for investigating other outcomes. Importantly, our method fits a very flexible
mixture model to capture the data distribution.
Several questions regarding the application of our method arise. We considered the case
when only A1c values are missing and include numerous covariates. In practice, EHRs will
suffer from incomplete information beyond A1c, such as the baseline variables in Table 2.1.
With multivariate incomplete variables, joint imputation or sequentially conditional imputa-
tion is necessary. It is also uncertain how many latent classes are needed. BPMI makes the
crucial assumption of conditional independence, given the latent classes. Likely, a greater
number of classes makes this assumption more plausible, but leads to difficulties including
covariates, especially those with low prevalence. Our diagnostics does not find evidence
against the assumed model. Future work will investigate the specific role of different as-
pects of patient complexity on the relationship of A1c to acute outcomes. This will address
substantive questions as well as further illuminate the plausibility of the imputations.
Several extensions of BPMI may be of interest. Besides the incorporation of time-varying
health outcomes into modeling, other time-varying variables including BP, BMI, and LDL
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can provide additional information to impute the A1c levels. To handle their high missingness
percentages, we can simultaneously model the trajectories and impute missing values via joint
mixture membership profiling (Airoldi et al. 2019). The number of latent profiles can be
treated as random in future work. With more information available from EHR, systematic
variable selection in an integrative inference framework needs further investigation. For
longitudinal data with intermittent missingness and nonlinear trajectories, it would be useful
to connect our joint modeling approach with existing approaches for monotone missingness
or weighting adjustments (Hogan and Daniels 2008; Robins et al. 2000).
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A Spline functions
B Posterior computation
Supplemental materials for the posterior computation under marginal and joint profiling.
B.1 Marginal profiling
The prior distributions are specified as: β ∼ N(0,Σβ), αl ∼ N(0,Σα), σ2l ∼ Inverse-Gamma: IG(a, b),
Σr ∼ Inverse-Wishart: IW(νb,Σb) and ηl ∼ N(bl, Bl), where we set the hyper-parameters
equal to 1 and assume independence in the covariance matrix specification. The posterior
updating follows the steps:
1. Update Ci: for i = 1, . . . , n, draw Ci from a multinomial distribution with probability
Pr(Ci = l) =
pil(Xi0, ηl)
∏
j f(Yij|β, αl, bi, σ2l , Di, D∗i , D∗∗i )∑
l pil(Xi0, ηl)
∏
j f(Yij|β, αl, bi, σ2l , Di, D∗i , D∗∗i )
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Figure A.1: Spline functions of time used as covariates inD∗ij with profile-specific coefficients.
The x-axis represents time in years.
2. Update αl: for l = 2, . . . , L, where α1 = 0 for identification purpose, pi(αl|−) =
N(µα, Vα), where Vαl = (Σ
−1
α +σ
−2
l D
∗′
l D
∗
l )
−1, µα = Vαlσ
−2
l D
∗′
l (Xl−Dlβ−D∗∗l bl). Here
Dl, D
∗
l , D
∗∗
l , Xl, bl are subsets of the design matrix and random effects for all i, j such
that Ci = l
3. Update ηl: for l = 2, . . . , L, let cil = I(Ci = l), pi(ηl) ∼ N(m∗l , S∗l ), where S∗l =
(V TΩlV +B
−1
l )
−1, V is the design matrix with each row XTi0, Ωl = diag(w1l, . . . , wnl),
and m∗l = S
∗
l (B
−1
l bl + V
Tml), where ml is a vector in R
n, and the ith component is
m
(i)
l = cil − 1/2 + wil{log[
∑
k 6=l exp(X
T
i0ηk)]}.
30
4. Update β ∼ N(µβ, Vβ),whereX∗i0 = D∗∗i ΣrD∗∗′i +σ2CiITi , Vβ = (Σ−1β +
∑
iD
′
iX
∗
i0
−1Di)−1,
and µβ = Vβ
∑
iD
′
iX
∗
i0
−1(Yi −D∗iαCi).
5. Update σ2l , for l = 1, . . . , L from IG(
∑
i:Ci=l
Ti/2 + a, (Yl −Dlβ −D∗l α−D∗∗l bl)′(Yl −
Dlβ −D∗l α−D∗∗l bl)/2 + b).
6. Update Σr from IW (n+ νb, b
′b+ Σb).
7. Update bi from N(µb, Vb), here Vb = (Σ
−1
r + σ
−2
Ci
D∗∗
′
i D
∗∗
i )
−1, and µb = Vbσ−2Ci D
∗∗′
i (Yi −
Diβ −D∗iαCi)
After convergence, we impute missing data from the assumed model for Y since this step
does not need to be included into the iterations.
B.2 Joint profiling
The prior distributions are specified as β ∼ N(0,Σβ), αl ∼ N(0,Σα), σ2l ∼ IG(a, b), Σr ∼
IW(νb,Σb), ηl ∼ N(bl, Bl), ν ∼ N(0,Σν), γl ∼ N(0,Σγ) and E ∼ IW (νe,Σe), where we
set the hyper-parameters equal to 1 and assume independence in the covariance matrix
specification. The posterior computation is the following.
1. Update Ci: for i = 1, . . . , n, draw Ci from a multinomial distribution with probability
Pr(Ci = l) =
pil(Xi0, ηl)
∏
j p
Rij
ij|Ci=l(1− pij|Ci=l)1−Rijf(Yij|β, αl, bi, σ2l , Di, D∗i , D∗∗i )∑
l pil(Xi0, ηl)
∏
j p
Rij
ij|Ci=l(1− pij|Ci=l)1−Rijf(Yij|β, αl, bi, σ2l , Di, D∗i , D∗∗i )
.
2. Update αl: for l = 2, . . . , L, where α1 = 0, pi(αl|−) = N(µα, Vα), where Vαl = (Σ−1α +
σ−2l D
∗′
l D
∗
l )
−1, µα = Vαlσ
−2
l D
∗′
l (Yl −Dlβ −D∗∗l bl).
3. Update ηl: for l = 2, . . . , L, pi(ηl) ∼ N(m∗l , S∗l ), where S∗l = (V TΩlV +B−1l )−1, V is the
design matrix with each rowXTi0, Ωl = diag(w1l, . . . , wnl), and m
∗
l = S
∗
l (B
−1
l bl+V
Tml),
where ml is a vector in R
n, and the ith component is
m
(i)
l = cil − 1/2 + wil{log[
∑
k 6=l
exp(XTi0ηk)]}
4. Update β: pi(β|−) = N(µβ, Vβ),X∗i0 = D∗∗i ΣrD∗∗′i +σ2CiITi , Vβ = (Σ−1β +
∑
iD
′
iX
∗
i0
−1Di)−1,
and µβ = Vβ
∑
iD
′
iX
∗
i0
−1(Yi −D∗iαCi).
5. Update σ2l , for l = 1, . . . , L, from IG(
∑
i:Ci=l
Ti/2 + 1, (Yl −Dlβ −D∗l α −D∗∗l b)′(Yl −
Dlβ −D∗l α−D∗∗l b)/2 + 1).
6. Update Σr from IW (n+ νb, b
′b+ Σb).
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7. Update bi from pi(bi|−) = N(µb, Vb), here Vb = (Σ−1r + σ−2Ci D∗∗
′
i D
∗∗
i )
−1, and µb =
Vbσ
−2
Ci
D∗∗
′
i (Yi −Diβ −D∗iαCi).
8. Update ν: [v|−] ∼ N(m∗v, S∗v), wherem∗v = S∗v(B>kv), B =
[
B>11, ..., B
>
1T1
, B>21, ..., B
>
nTn
]>
and
kv is a vector with length
∑n
i=1 Ti:
kv =
[
k∗11 − w∗11((B∗11)>γC1 + (B∗∗11)>e1)), ..., k∗nTn − w∗nTn((B∗nTn)>γCn + (B∗∗nTn)>en))
]>
and S∗v = (Σ
−1
v +B
>ΩvB)−1, where Ωv = diag(w∗11, ..., w
∗
1T1
, w∗21, ..., w
∗
2T2
, ..., w∗n1, ..., w
∗
nTn
).
9. Update γl, for l = 2, . . . , k, from [γl|−] ∼ N(m∗γl , S∗γl), where m∗γl = S∗γl((B∗)>kγl),
B∗l =
[
(B∗11)
>I(C1 = l), ..., (B∗1T1)
>I(C1 = l), (B∗21)
>I(C2 = l), ..., B∗nTn)
>I(Cn = l)
]>
and kγl is a vector with length
∑
i:Ci=l
Ti:
kγl =
[ {k∗11 − w∗11(B>11ν + (B∗∗11)>e1)}I(C1 = l), ..., {k∗nTn − w∗nTn(B>nTnν + (B∗∗nTn)>en)}I(Cn = l) ]>
and S∗γl = (Σ
−1
γl
+ (B∗)>ΩγlB
∗)−1, where Ωγl = diag(w
∗
11I(C1 = l), ..., w
∗
1T1
I(C1 =
l), w∗21I(C2 = l), ..., w
∗
2T2
I(C2 = l), ..., w
∗
n1I(Cn = l), ..., w
∗
nTn
I(Cn = l)).
10. Update ei from [ei|−] ∼ N(m∗ei , S∗ei), wherem∗ei = S∗ei((B∗∗i )>kei), B∗∗i =
[
(B∗i1)
>, ..., (B∗iTi)
> ]>
and kei is a vector of R
Ti as the following:
kei =
[
k∗i1 − w∗i1(B>i1ν + (B∗i1)>γC1), ..., k∗iTi − w∗iTi(B>iTiν + (B∗iTi)>γCi)
]>
and S∗ei = (E
−1 + ((B∗∗i )
>ΩeiB
∗∗
i )
−1, where Ωei = diag(w
∗
i1, ..., w
∗
iTi
).
11. Update E from IW (n+ νe,
∑n
i=1 eie
ᵀ
i + Σe).
12. Impute missing data: draw Y ∗ij from f(Yij|β, αCi , bi, σ2Ci , Di, D∗ij, D∗∗i ) .
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